|
1
|
Aberle DR, Adams AM, Berg CD, Black WC,
Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM and Sicks
JD; National Lung Screening Trial Research Team: Reduced
lung-cancer mortality with low-dose computed tomographic screening.
N Engl J Med. 365:395–409. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu H, Qiao N, Wang Y, Jiang M, Wang S,
Wang C and Hu L: Association between the telomerase reverse
transcriptase (TERT) rs2736098 polymorphism and cancer risk:
Evidence from a case-control study of non-small-cell lung cancer
and a meta-analysis. PLoS One. 8:e763722013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu J, Yin Z, Gao W, Liu L, Yin Y, Liu P
and Shu Y: Genetic variation in a microRNA-502 minding site in SET8
gene confers clinical outcome of non-small cell lung cancer in a
Chinese population. PLoS One. 8:e770242013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu XH, Liu ZL, Sun M, Liu J, Wang ZX and
De W: The long non-coding RNA HOTAIR indicates a poor prognosis and
promotes metastasis in non-small cell lung cancer. BMC Cancer.
13:4642013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Pao W and Girard N: New driver mutations
in non-small-cell lung cancer. Lancet Oncol. 12:175–180. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dela Cruz CS, Tanoue LT and Matthay RA:
Lung cancer: Epidemiology, etiology, and prevention. Clin Chest
Med. 32:605–644. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Raz DJ, Gomez SL, Chang ET, Kim JY, Keegan
TH, Pham J, Kukreja J, Hiatt RA and Jablons DM: Epidemiology of
non-small cell lung cancer in Asian Americans: Incidence patterns
among six subgroups by nativity. J Thorac Oncol. 3:1391–1397. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Albain KS, Swann RS, Rusch VW, Turrisi AT
III, Shepherd FA, Smith C, Chen Y, Livingston RB, Feins RH, Gandara
DR, et al: Radiotherapy plus chemotherapy with or without surgical
resection for stage III non-small-cell lung cancer: A phase III
randomised controlled trial. Lancet. 374:379–386. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kitano H, Chung JY, Ylaya K, Conway C,
Takikita M, Fukuoka J, Doki Y, Hanaoka J and Hewitt SM: Profiling
of phospho-AKT, phospho-mTOR, phospho-MAPK and EGFR in non-small
cell lung cancer. J Histochem Cytochem. 62:335–346. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee SH, Suh IB, Lee EJ, Hur GY, Lee SY,
Lee SY, Shin C, Shim JJ, In KH, Kang KH, et al: Relationships of
coagulation factor XIII activity with cell-type and stage of
non-small cell lung cancer. Yonsei Med J. 54:1394–1399. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Song G, Qin T, Liu H, Xu GB, Pan YY, Xiong
FX, Gu KS, Sun GP and Chen ZD: Quantitative breath analysis of
volatile organic compounds of lung cancer patients. Lung Cancer.
67:227–231. 2010. View Article : Google Scholar
|
|
12
|
Ma H, Shu Y, Pan S, Chen J, Dai J, Jin G,
Hu Z and Shen H: Polymorphisms of key chemokine genes and survival
of non-small cell lung cancer in Chinese. Lung Cancer. 74:164–169.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singh S, Sadanandam A and Singh RK:
Chemokines in tumor angiogenesis and metastasis. Cancer Metastasis
Rev. 26:453–467. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Niens M, Visser L, Nolte IM, van der
Steege G, Diepstra A, Cordano P, Jarrett RF, Te Meerman GJ, Poppema
S and van den Berg A: Serum chemokine levels in Hodgkin lymphoma
patients: Highly increased levels of CCL17 and CCL22. Br J
Haematol. 140:527–536. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Freier CP, Kuhn C, Rapp M, Endres S, Mayr
D, Friese K, Anz D and Jeschke U: Expression of CCL22 and
infiltration by regulatory T cells are increased in the decidua of
human miscarriage placentas. Am J Reprod Immunol. 74:216–227. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tete S, Tripodi D, Rosati M, Conti F,
Maccauro G, Saggini A, Cianchetti E, Caraffa A, Antinolfi P,
Toniato E, et al: IL-37 (IL-1F7) the newest anti-inflammatory
cytokine which suppresses immune responses and inflammation. Int J
Immunopathol Pharmacol. 25:31–38. 2012.PubMed/NCBI
|
|
17
|
Nold MF, Nold-Petry CA, Zepp JA, Palmer
BE, Bufler P and Dinarello CA: IL-37 is a fundamental inhibitor of
innate immunity. Nat Immunol. 11:1014–1022. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu D, Wang A, Jiang F, Hu J and Zhang X:
Effects of interleukin-37 on cardiac function after myocardial
infarction in mice. Int J Clin Exp Pathol. 8:5247–5251.
2015.PubMed/NCBI
|
|
19
|
Xia L, Shen H and Lu J: Elevated serum and
synovial fluid levels of interleukin-37 in patients with rheumatoid
arthritis: Attenuated the production of inflammatory cytokines.
Cytokine. 76:553–557. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang G, Yu D, Tan W, Zhao D, Wu C and Lin
D: Genetic polymorphism in chemokine CCL22 and susceptibility to
Helicobacter pylori infection-related gastric carcinoma. Cancer.
115:2430–2437. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Erfani N, Nedaei Ahmadi AS, Ghayumi MA and
Mojtahedi Z: Genetic polymorphisms of CCL22 and CCR4 in patients
with lung cancer. Iran J Med Sci. 39:367–373. 2014.PubMed/NCBI
|
|
22
|
Dougan M, Li D, Neuberg D, Mihm M, Googe
P, Wong KK and Dranoff G: A dual role for the immune response in a
mouse model of inflammation-associated lung cancer. J Clin Invest.
121:2436–2446. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jin Y, Xiong X, Su Y, Hu J and Tao X:
Serum vascular endothelial growth factor levels in patients with
non-small cell lung cancer and its relations to the micrometastasis
in peripheral blood. J Huazhong Univ Sci Technolog Med Sci.
29:462–465. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Thelen M and Stein JV: How chemokines
invite leukocytes to dance. Nat Immunol. 9:953–959. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Speyer CL and Ward PA: Role of endothelial
chemokines and their receptors during inflammation. J Invest Surg.
24:18–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xia S, Wei J, Wang J, Sun H, Zheng W, Li
Y, Sun Y, Zhao H, Zhang S, Wen T, et al: A requirement of dendritic
cell-derived interleukin-27 for the tumor infiltration of
regulatory T cells. J Leukoc Biol. 95:733–742. 2014. View Article : Google Scholar
|
|
27
|
Boraschi D, Lucchesi D, Hainzl S, Leitner
M, Maier E, Mangelberger D, Oostingh GJ, Pfaller T, Pixner C,
Posselt G, et al: IL-37: A new anti-inflammatory cytokine of the
IL-1 family. Eur Cytokine Netw. 22:127–147. 2011.PubMed/NCBI
|
|
28
|
Ma P, Gu B, Xiong W, Tan B, Geng W, Li J
and Liu H: Glimepiride promotes osteogenic differentiation in rat
osteoblasts via the PI3K/Akt/eNOS pathway in a high glucose
microenvironment. PLoS One. 9:e1122432014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Maloy KJ and Powrie F: Intestinal
homeostasis and its breakdown in inflammatory bowel disease.
Nature. 474:298–306. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lindsey S and Langhans SA: Crosstalk of
oncogenic signaling pathways during epithelial-mesenchymal
transition. Front Oncol. 4:3582014. View Article : Google Scholar
|
|
31
|
Nagathihalli NS and Merchant NB:
Src-mediated regulation of E-cadherin and EMT in pancreatic cancer.
Front Biosci. 17:2059–2069. 2012. View
Article : Google Scholar
|
|
32
|
Li MX and Liu BC: Epithelial to
mesenchymal transition in the progression of tubulointerstitial
fibrosis. Chin Med J. 120:1925–1930. 2007.PubMed/NCBI
|
